Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.37 $15.43 Thursday, 9th May 2024 URGN stock ended at $12.97. This is 2.26% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 4.81% from a day low at $12.60 to a day high of $13.21.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Apr 18, 2018 $61.12 $62.03 $57.50 $57.88 90 745
Apr 17, 2018 $59.92 $63.46 $59.30 $60.56 133 711
Apr 16, 2018 $60.38 $61.53 $58.06 $59.60 89 241
Apr 13, 2018 $61.33 $63.39 $59.14 $59.29 88 548
Apr 12, 2018 $64.26 $64.80 $60.40 $60.98 80 510
Apr 11, 2018 $64.37 $64.77 $61.25 $62.72 64 605
Apr 10, 2018 $60.83 $66.38 $60.62 $62.99 166 989
Apr 09, 2018 $59.08 $64.12 $59.08 $60.10 168 326
Apr 06, 2018 $60.93 $62.07 $58.60 $59.08 202 068
Apr 05, 2018 $63.26 $65.89 $58.29 $59.56 171 947
Apr 04, 2018 $60.00 $65.49 $59.64 $63.23 296 189
Apr 03, 2018 $53.51 $61.77 $51.19 $59.80 629 291
Apr 02, 2018 $49.81 $50.14 $47.38 $48.35 62 987
Mar 29, 2018 $50.43 $51.29 $48.20 $49.69 130 578
Mar 28, 2018 $52.40 $52.70 $48.37 $49.88 150 249
Mar 27, 2018 $54.45 $54.45 $52.00 $52.42 111 260
Mar 26, 2018 $51.00 $55.14 $51.00 $54.55 154 855
Mar 23, 2018 $53.65 $54.51 $50.01 $50.65 49 321
Mar 22, 2018 $53.31 $55.92 $51.13 $54.30 100 184
Mar 21, 2018 $53.06 $54.46 $52.81 $53.76 58 806
Mar 20, 2018 $53.40 $54.64 $50.01 $53.20 62 201
Mar 19, 2018 $52.86 $54.31 $51.06 $53.24 88 070
Mar 16, 2018 $56.77 $57.09 $53.59 $54.19 97 498
Mar 15, 2018 $57.47 $57.47 $54.02 $56.38 156 244
Mar 14, 2018 $55.99 $58.12 $54.02 $57.54 80 048
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT